The Trump administration is expected to unveil an executive action in the near future that would significantly restrict temporary (“nonimmigrant”) work visa categories. While there are multiple public data sets available from the Department of Homeland Security and the Department of State relevant to these visa categories, they are unfortunately not sufficient to answer these basic questions with great precision: How many individuals enter the country each year, for the first time, using each of these visa categories? How many individuals are already in the United States at any given moment, having previously entered using each of these visa categories?
The goal of this report is to synthesize the relevant data and clearly present what it can—and cannot—reveal about the number of individuals potentially impacted by work visa restrictions. You can read the full report here.
You can learn more about the Technology and Innovation Initiative here.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.
The U.S. should create a new non-governmental Innovation Accelerator modeled after the successful In-Q-Tel program to invest in small and mid-cap companies creating technologies that address critical needs of the United States.